Uttar Pradesh, India

Sonal Shree


Average Co-Inventor Count = 15.0

ph-index = 1


Company Filing History:


Years Active: 2020

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Sonal Shree: Innovator in Cancer Therapy

Introduction

Sonal Shree is a prominent inventor based in Uttar Pradesh, India. She has made significant contributions to the field of medical science, particularly in the treatment of chronic myeloid leukemia (CML). Her innovative approach has the potential to improve the lives of many patients suffering from this challenging condition.

Latest Patents

Sonal Shree holds a patent for a groundbreaking invention titled "Combination of clofazimine and imatinib for effective therapy of drug-resistant myeloid leukemia." This invention relates to a method of treating chronic myeloid leukemia or drug-resistant CML. It involves administering a therapeutically effective amount of Clofazimine (CFZ) or its pharmaceutically acceptable derivatives, analogues, salts, or compositions. Additionally, the invention includes a combination of Clofazimine with a tyrosine kinase inhibitor (TKI). The patent also provides a kit for the treatment of CML or drug-resistant CML. She has 1 patent to her name.

Career Highlights

Sonal Shree is associated with the Council of Scientific & Industrial Research, where she has been instrumental in advancing research in cancer therapies. Her work has garnered attention for its innovative approach and potential impact on patient care.

Collaborations

Sonal has collaborated with notable colleagues such as Sabyasachi Sanyal and Harish Kumar. Their combined expertise has contributed to the success of her research and inventions.

Conclusion

Sonal Shree's contributions to cancer therapy exemplify the power of innovation in medicine. Her work not only highlights her dedication to scientific advancement but also offers hope for improved treatment options for patients with chronic myeloid leukemia.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…